Congress delegates are invited to submit abstracts of their scientific work for presentation as a free communication at Euromedlab Athens 2017.

An unlimited number of abstracts may be submitted provided the presenting author applies for “full registration”. Abstracts are welcome in all fields of clinical chemistry, haematology, clinical molecular biology and laboratory medicine, in the broader sense. Free communications are primarily presented via poster. A limited number of abstracts will be selected for oral presentation during symposia (two abstracts for each symposium). Authors wishing to compete for these oral communication slots should mark the appropriate field on the on-line abstract-submission form. Properly submitted abstracts will be sent to experts for review and selection for oral communication.


  1. Advanced technologies - New biomarker discovery
  2. Analytical technologies and applications
  3. Atherosclerosis - Lipids and Lipoproteins
  4. Autoimmune diseases - Allergy
  5. Bioinformatics - Information technology applications
  6. Biology of extreme ages - Pediatric and Geriatric laboratory medicine - Prenatal and postnatal testing
  7. Biomarkers in cancer
  8. Bone metabolism - Osteoporosis
  9. Cardiovascular diseases - Cardiac markers
  10. Clinical Studies - Outcomes
  11. Critical care, Emergency medicine, Blood gases, POCT
  12. Education and Training in Laboratory Medicine
  13. Endocrinology
  14. Evidence based medicine - Guidelines
  15. Gastrointestinal diseases
  16. Hematology - Hemostasis
  17. Inflammation, Vascular biology, Endothelium, Oxidative stress
  18. Inherited disorders - Metabolic disorders
  19. Kidney diseases
  20. Laboratory and Sports medicine
  21. Laboratory Management, Accreditation, Quality Assurance
  22. Microbiology - Infectious diseases
  23. Molecular diagnostics - Genetic testing
  24. Neurological - Neurodegenerative diseases
  25. Nutrition, Vitamins and Trace Elements
  26. Obesity, Metabolic syndrome, Diabetes
  27. Patient sample management, (standardization, harmonization,reference ranges, etc)
  28. Pharmacogenetics - Personalized Medicine
  29. Rare Diseases
  30. Toxicology - Therapeutic Drug Monitoring


The text must be clear, concise, and written in proper English. The content must not have been previously published in academic journals or subject to peer review. Significant technical information must not be withheld. Abstracts must absolutely contain results. Statements such as “results will be discussed” are not acceptable and will lead to rejection.


Abstracts can be structured and may include:
a brief introduction stating the purpose of the investigation and its relevance to laboratory medicine;

a description of the methodology used;

to be supported by statistical or other evidence to show their validity;

The body of the abstract must not exceed 2300 characters, spaces included.


Deadline for receipt: Abstracts should be submitted by 6th November 2016, 23:59 CET.

Confirmation of receipt: Receipt of the abstract will be acknowledged by e-mail immediately after submission.

Possibility of revision: Authors have the possibility to revise the paper after the submission (within 6th November 2016) using the password received through the confirmation.

Notification of acceptance or rejection: Authors will be notified of acceptance or rejection before 20 December 2016.

Registration: The presenting author of each abstract must register for the congress with “Full Registration”.


Abstract authors are asked to indicate the most suitable topic for presentation of their work and will also be asked whether they wish apply for an oral presentation during the scientific symposia. In that case, authors must also select the symposium in which they would like to give their presentation.
Page sponsored by
More information available soon
New deadline for abstracts submission:

6 November 2016!